- $57.38bn
- $55.03bn
- $5.30bn
- 98
- 13
- 91
- 74
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,163 | 2,594 | 3,342 | 4,417 | 5,305 |
Cost of Revenue | |||||
Gross Profit | 1,657 | 2,024 | 2,559 | 3,333 | 4,068 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,816 | 2,067 | 2,692 | 3,448 | 4,064 |
Operating Profit | 347 | 528 | 650 | 970 | 1,241 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 386 | 542 | 628 | 956 | 1,334 |
Provision for Income Taxes | |||||
Net Income After Taxes | 330 | 489 | 614 | 925 | 1,190 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 332 | 489 | 607 | 857 | 1,148 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 332 | 489 | 607 | 857 | 1,148 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.38 | 0.544 | 0.721 | 1.06 | 1.45 |